QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Monopar Therapeutics (MNPR) Institutional Ownership

$1.12
+0.55 (+96.49%)
(As of 02/22/2024 ET)

Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)

Current
Institutional Ownership
Percentage
6.18%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$55,774.88
Number of
Institutional Sellers
(last 12 months)
0
Get MNPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MNPR Institutional Buying and Selling by Quarter


Monopar Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/31/2023Windsor Advisory Group LLC89,974$56K0.1%N/A0.635%
8/11/2022UBS Group AG19,561$45K0.0%+529.8%0.155%
8/13/2021Geode Capital Management LLC28,761$0.17M0.0%+9.0%0.229%
8/13/2021Vanguard Group Inc.97,462$0.57M0.0%+116.2%0.775%
5/21/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099%
5/18/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099%
5/17/2021Royal Bank of Canada9,130$57K0.0%N/A0.073%
5/12/2021Northern Trust Corp36,001$0.22M0.0%-38.8%0.286%
5/12/2021Geode Capital Management LLC26,394$0.16M0.0%N/A0.210%
5/7/2021BlackRock Inc.11,229$70K0.0%+108.3%0.089%
2/11/2021Northern Trust Corp58,793$0.36M0.0%-9.2%0.513%
2/5/2021BlackRock Inc.5,391$33K0.0%+99.4%0.047%
2/10/2020Bank of Montreal Can13,000$0.22M0.0%N/A0.123%
(Data available from 1/1/2016 forward)













MNPR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MNPR shares?

During the previous two years, the following institutional investors and hedge funds held shares of Monopar Therapeutics shares: Windsor Advisory Group LLC ($56K), UBS Group AG ($45K).Learn more on MNPR's institutional investors.

What percentage of Monopar Therapeutics stock is owned by institutional investors?

6.18% of Monopar Therapeutics stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings.

Which institutional investors have been buying Monopar Therapeutics stock?

The following institutional investors have purchased Monopar Therapeutics stock in the last 24 months: Windsor Advisory Group LLC ($89.97K), and UBS Group AG ($16.46K).

How much institutional buying is happening at Monopar Therapeutics?

Institutional investors have bought a total of 106,429 shares in the last 24 months. This purchase volume represents approximately $93.62K in transactions.


This page (NASDAQ:MNPR) was last updated on 2/22/2024 by MarketBeat.com Staff